Used in targeted cancer therapies, particularly in inhibiting tumor growth and metastasis by blocking the AXL receptor tyrosine kinase, which is overexpressed in various cancers including lung, breast, and pancreatic cancers. It modulates immune responses in the tumor microenvironment, enhancing the efficacy of immunotherapies and overcoming drug resistance. Also employed as a research tool to study AXL signaling pathways and for diagnostic applications in detecting AXL-positive tumor cells. Shows potential in combination therapies with chemotherapy, radiation, or other targeted agents to improve clinical outcomes.